𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women

✍ Scribed by S.J.M Neele; R Evertz; G De Valk-De Roo; J.C Roos; J.C Netelenbos

Book ID
117807584
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
66 KB
Volume
30
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Odanacatib in the treatment of postmenop
Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect
✍ John A Eisman; Henry G Bone; David J Hosking; Michael R McClung; Ian R Reid; Ren πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 211 KB πŸ‘ 2 views

## Abstract The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral density (BMD) and decreased bone‐resorption markers during 2 years of treatment in postmenopausal women with low BMD. A 1‐year extension study further assessed ODN efficacy and safety and the effec